By GREGORY ZELLER //
Already knee-deep in word-class medical science, Long Island healthcare has been bolstered by the arrival of a nationally renowned cancer center.
Brandishing the bold slogan “We can cure cancer in our lifetime,” NYU Langone’s Perlmutter Cancer Center, a National Cancer Institute-designated research and treatment center, is expanding its clinical and laboratory activities on Long Island with the opening of a state-of-the-art Huntington facility.
Complementing existing Laura and Isaac Perlmutter Cancer Center facilities in Manhattan, Brooklyn and Queens, the 22,000-square-foot Huntington center – which officially opened Aug. 7 – more than doubles the Perlmutter cancer program in the Huntington community, when combined with the NYU Langone Huntington Medical Group.
The Huntington Medical Group, a Huntington Station fixture for more than half a century, is already one of the NYU Langone Health System’s largest ambulatory practices.
Boasting an interdisciplinary staff of five nurses, nine physicians – including three oncologists, three rheumatologists and three neurologists – and 23 professionals total, the Perlmutter Cancer Center-Huntington includes 24 “infusion bays” and 16 separate examination rooms.
The center is equipped to handle upwards of 30,000 patient visits annually, providing infusion treatments – medication administered directly into the bloodstream through an intravenous catheter – for breast, pancreatic and other cancers, as well as a range of chronic conditions including Crohn’s disease, multiple sclerosis, rheumatoid arthritis and lupus, among others.
Perlmutter Cancer Center Director Benjamin Neel said the new Huntington facility was designed to spare thousands of Long Island-based patients in need of topflight cancer care the long trip into NYC.
“We understand the impact cancer has on individuals, families and communities, and the burden of trying to access the highest quality of care miles away in Manhattan,” Neel said. “With the opening of our site in Huntington, we can bring our services directly to Long Island patients who want to be treated at our world-class cancer center.”
Like other Perlmutter Cancer Center facilities, the Huntington operation features indigenous diagnostic laboratories, private infusion bays with televisions and WiFi access, physician’s offices and complementary refreshments for patients and caregivers.
Perlmutter patients can also access up-to-date test results, schedule appointments and communicate with their doctors through MyChart, the patient portal of Epic, NYU Langone’s system-wide electronic health-records system.
In addition to roughly a dozen full-on Cancer Centers, NYU Langone maintains several Perlmutter satellite facilities around Greater New York, including centers focused on one specific type of cancer – a Manhattan-based Brain Tumor Center, for instance – as well as numerous physician’s offices and clinics adding their own specialized cancer services.
Known for excellence in clinical care and research, NYU Langone Health is an integrated academic medical center with more than 200 satellite locations throughout Greater New York. The system also operates the NYU School of Medicine, which has trained physicians and scientists since 1841.
Doubling down on its Perlmutter cancer services in centralized Huntington – as opposed to opening a new Perlmutter satellite somewhere else on the Island – was basically a matter of geography, according to Neel. Not only did NYU Langone have a running start with its Huntington Medical Group, but New York State Department of Health statistics show that cancer mortality rates for both men and woman run higher in Suffolk than in Nassau, Neel noted.
“By bringing our state-of-the art, cutting-edge care directly to the community, we hope to improve these unacceptable outcomes,” the director said Monday.